Nalaganje...
An alternate conformation of HCV E2 neutralizing face as an additional vaccine target
To achieve global elimination of hepatitis C virus (HCV), an effective cross-genotype vaccine is needed. The HCV envelope glycoprotein E2 is the main target for neutralizing antibodies (nAbs), which aid in HCV clearance and protection. E2 is structurally flexible and functions in engaging host recep...
Shranjeno v:
| izdano v: | Sci Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Association for the Advancement of Science
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7380959/ https://ncbi.nlm.nih.gov/pubmed/32754640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.abb5642 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|